Vicarious Surgical continues to expect full year 2026 cash burn of approximately $19 million, indicating ongoing capital expenditure needs for the company's operations.
Bullish
Vicarious Surgical significantly reduced its net loss to $7.3 million in Q1 2026, driven by a 52% decrease in total operating expenses, including substantial reductions in R&D and G&A.
Bearish
Vicarious Surgical expects a $19 million cash burn for 2026 and experienced a substantial decline in current assets, alongside significant risks in product approval and commercialization.